Host Markers and Prognosis in Recurrent Rectal Carcinomas Treated with Radiotherapy

References

• MacFarlane J K, Ryall R DH, Heald R J. Mesorectal excision for rectal cancer. Lancet 1993; 341: 457–60
   PubMed Web of Science ®Google Scholar
• Bentzen S M, Balslev I, Pedersen M. Time to loco-regional recurrence after resection of Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A multivariate regression analysis. Br J Cancer 1992; 65: 102–7
   PubMed Web of Science ®Google Scholar
• Lybeert M L, Martijn H, de-Neve W, Crommelin M A, Ribot J G. Radiotherapy for locoregional relapses of rectal carcinoma after initial radical surgery: Definite but limited influence on relapse-free survival and survival. Int J Radiat Oncol Biol Phys 1992; 24: 241–6
   PubMed Web of Science ®Google Scholar
• Wong C S, Cummings B J, Keane T J, O'Sullivan B, Catton C N. Results of external beam irradiation for rectal carcinomas locally recurrent after local excision or electrocoagulation. Radiother Oncol 1991; 22: 145–8
   PubMed Web of Science ®Google Scholar
• Davey P, Arnott S J, Sturgeon C M. Carcinoembryonic antigen as a prognostic indicator in the radiotherapeutic management of rectal cancer. Eur J Surg Oncol 1987; 13: 17–20
   PubMedGoogle Scholar
• Edler L, Heim M E, Quintero C, Brummer T, Queisser W. Prognostic factors of advanced colorectal cancer patients. Eur J Cancer Clin Oncol 1986; 22: 1231–7
   PubMedGoogle Scholar
• The Committee on Enzymes of the Scandinavian Society for Clinical Chemistry and Clinical Physiology. Recommended methods for the determination of four enzymes in blood. Scand J Clin Lab Invest 1974; 33: 291–306
   PubMed Web of Science ®Google Scholar
• The Committee on Enzymes of the Scandinavian Society for Clinical Chemistry and Clinical Physiology. Recommended methods for the determination of gamma-glutamyltransferase in blood. Scand J Clin Lab Invest 1976; 36: 119–25
   PubMed Web of Science ®Google Scholar
• Banner O P. Standardization, specificity, and diagnostic sensitivity of four immunoassays for carcinoembryonic antigen. Clin Chem 1991; 37: 231–6
   PubMedGoogle Scholar
• Dixon W J, Brown M B, Engelman L, Jennrich R I. BMDP statistical software manual. University of California Press, Berkeley 1990
   Google Scholar
• Peto R, Pike M C, Armitage P. Design and analysis of randomized clinical trials requiring prolonged observation for each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1–39
   PubMed Web of Science ®Google Scholar
• Cox R D. Regression models and life-tables. J R Stat Soc 1972; 34: 187–220
   Google Scholar
• Wiggers T, Arends J W, Volovics A. Regression analysis of prognostic factors in colorectal cancer after curative resections. Dis Colon Rectum 1988; 31: 33–41
   PubMed Web of Science ®Google Scholar
• Hannisdal E, Thorsen G. Regression analyses of prognostic factors in colorectal cancer. J Surg Oncol 1988; 37: 109–12
   PubMed Web of Science ®Google Scholar
• Gislason T, Nou E. Sedimentation rate, leucocytes, platelet count and haemoglobin in bronchial carcinoma: An epidemio-logical study. Eur J Respir Dis 1985; 66: 141–6
   PubMedGoogle Scholar
• Hernandez E, Lavine M, Dunton C J, Gracely E, Parker J. Poor prognosis associated with thrombocytosis in patients with cervical cancer. Cancer 1992; 69: 2975–7
   PubMed Web of Science ®Google Scholar
• Higashihara M, Sunaga S, Tange T, Oohashi H, Kurokawa K. Increased secretion of Interleukin-6 in malignant mesothe-lioma cells from a patient with marked thrombocytosis. Cancer 1992; 70: 2105–8
   PubMedGoogle Scholar
• Suzuki A, Takahashi T, Nakamura K. Thrombocytosis in patients with tumors producing colony-stimulating factor. Blood 1992; 80: 2052–9
   PubMedGoogle Scholar
• Kitamura H, Kodama F, Odagiri S, Nagahara N, Inoue T, Kanisawa M. Granulocytosis associated with malignant neoplasms: A clinicopathologic study and demonstration of colony-stimulating activity in tumor extracts. Hum Pathol 1989; 20: 878–85
   PubMedGoogle Scholar
• Honn K V, Tang D G, Crissman J D. Platelets and cancer metastasis: a causal relationship?. Cancer Metastasis Rev 1992; 11: 325–51
   PubMed Web of Science ®Google Scholar
• Johansson J E, Sigurdsson T, Holmberg L, Bergström R. Erythrocyte sedimentation rate as a tumor marker in human prostatic cancer: An analysis of prognostic factors in 300 population-based consecutive cases. Cancer 1992; 70: 1556–63
   PubMed Web of Science ®Google Scholar
• Seifter E J, Parker R I, Gralnick H R. Abnormal coagulation results in patients with Hodgkin's disease. Am J Med 1985; 78: 942–50
   PubMed Web of Science ®Google Scholar
• Hu D, Ruan J. Haemorheological investigation of patients with nasopharyngeal carcinoma. Clin Hemorheol 1988; 8: 891–900
   Google Scholar
• Wojtukiewicz M Z, Zacharski L R, Moritz T E, Hur K, Edwards R L, Rickles F R. Prognostic significance of blood coagulation tests in carcinoma of the lung and colon. Blood Coagul Fibrinolysis 1992; 3: 429–37
   PubMed Web of Science ®Google Scholar
• Costantini V, Zacharski L R. The role of fibrin in tumor metastasis. Cancer Metastasis Rev 1992; 11: 283–90
   PubMedGoogle Scholar
• Dvorak H F. Tumors: Wounds that do not heal: Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315: 1650–9
   PubMed Web of Science ®Google Scholar
• Zacharski L R, Meehan K R, Algarra S M, Calvo F A. Clinical trials with anticoagulant and antiplatelet therapies. Cancer Metastasis Rev 1992; 11: 421–31
   PubMed Web of Science ®Google Scholar
• Stamatiadis A P, St Toumanidou M, Vyssoulis G P, Manouras A J, Apostolidis N S. Value of serum acute-phase reactant proteins and carcinoembryonic antigen in the preop-erative staging of colorectal cancer: A multivariate analysis. Cancer 1990; 65: 2055–7
   PubMed Web of Science ®Google Scholar
• Bernacka K, Kuryliszyn Moskal A, Sierakowski S. The levels of alpha 1-antitrypsin and alpha 1-antichymotrypsin in the sera of patients with gastrointestinal cancers during diagnosis. Cancer 1988; 62: 1188–93
   PubMedGoogle Scholar
• Bataille R, Boccadoro M, Klein B, Durie B, Pileri A. C-reac-tive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system. Blood 1992; 80: 733–7
   PubMed Web of Science ®Google Scholar
• Steinberg J, Erlichman C, Gadalla T, Fine S, Wong A. Prognostic factors in patients with metastatic colorectal cancer receiving 5-fluorouracil and folinic acid. Eur J Cancer 1992; 28A: 1817–20
   PubMedGoogle Scholar
• Schwartz M K. Enzymes as prognostic markers and therapeutic indicators in patients with cancer. Clin Chim Acta 1992; 206: 77–82
   PubMed Web of Science ®Google Scholar
• Chapman J A, Trudeau M E, Pritchard K I. A comparison of all-subset Cox and accelerated failure time models with Cox step-wise regression for node-positive breast cancer. Breast Cancer Res Treat 1992; 22: 263–72
   PubMed Web of Science ®Google Scholar